• Aztiq-Innobic consortium to buy Alvogen subsidiary for $475m Pharmaceutical-Technology
    November 29, 2021
    A consortium led by Icelandic pharmaceutical investment fund Aztiq and Thailand-based life sciences company Innobic has agreed to acquire all shares of Alvogen Emerging Market Holdings (AEMH) from its current stakeholders for $475m.
PharmaSources Customer Service